{"disease":{"id":"paralytic-lagophthalmos","name":"paralytic lagophthalmos"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06291818","title":"Self-Adhering Magnetic Device to Treat Corneal Exposure","phase":"NA","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"University of Illinois at Chicago","has_results":false},{"nct_id":"NCT04944498","title":"Modified Tarsorrhaphy vs Gold Weight Implant for Paralytic Lagophthalmos in Leprosy Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Yunia Irawati","has_results":false},{"nct_id":"NCT03848260","title":"A Real-Time Magnetic Device Prototype for Temporary Management of Paralytic Lagophthalmos","phase":"NA","overall_status":"SUSPENDED","enrollment_count":12,"lead_sponsor_name":"E-DA Hospital","has_results":false},{"nct_id":"NCT06895902","title":"Suture Lid Spring for Lid Closure in Patients With Facial Nerve Palsy","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"University of Alberta","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}